Tiger X Medical Inc.
Could not find a ticker for this position, may be a filing error
A regenerative medicine company that develops cell therapies to repair damaged heart tissue in people with heart failure. Its CardiAMP therapy uses a patient's own bone marrow cells, prepared at the bedside and delivered into the heart with the Helix delivery system. The company began as Cardo Medical in 1994 and took its current form in 2016, when it merged with the shell company Tiger X Medical and adopted the BioCardia name.
No proxy statement recorded.